Table 1. Estimations of the Prevalence of HBV Infection in the General Population of Iran and its Provinces.
Province | Study’s first author (year of publication) | Year of Study | Total No. | Male No. | HBV Prevalence estimates % (95% CI) | Reference |
---|---|---|---|---|---|---|
Charmahal and Bakhtiari | Moezzi (2014) | 2012 - 2013 | 3000 | 1111 | 1.3 (0.9 - 1.7) | (30) |
East Azarbaijan | Bayat-Makou (2003) | 2000 | 381 | ND | 1.2 (0.1 - 2.3) | (31) |
Golestan | ||||||
Study 1 | Pourshams (2004) | 2003 | 1035 | 438 | 4.3 (3 - 5.5) | (24) |
Study 2 | Roshandel (2007) | 2004 - 2005 | 1850 | 877 | 8.9 (7.6 - 10.2) | (14) |
Study 3 | Merat (2009)a | 2006 | 1896 | 607 | 5.1 (4.1 - 6.1) | (23) |
Total | 6.1 (3.5 - 8.7) | |||||
Hamadan | ||||||
Study 1 | Amini (1993) | 1989 | 4930 | 1649 | 2.5 (2.1 - 2.9) | (25) |
Study 2 | Alizadeh (2006) | 2003 | 1824 | 1025 | 2.3 (1.6 - 3) | (12) |
Total | 2.4 (2.1 - 2.8) | |||||
Hormozgan | Merat (2009)a | 2006 | 1455 | 658 | 2.7 (1.9 - 3.5) | (23) |
Isfahan | Nokhodian (2009) | 2006 | 816 | 388 | 1.3 (0.5 - 2.1) | (32) |
Kermanshah | Alavian (2012) | 2010 | 1979 | 990 | 0.7 (0.4 - 1.1) | (33) |
Kordestan | Alavian (2012) | 2010 | 1613 | 548 | 0.8 (0.4 - 1.2) | (34) |
Mazandaran | Keyvani (2014) | 2008 - 2011 | 6146 | 3472 | 0.9 (0.7- 1.2) | (35) |
Qom | Ghadir (2012) | 2010 | 3666 | 1709 | 1.3 (0.9 - 1.7) | (36) |
Razavi Khorasan | ||||||
Study 1 | Farhat (2003) | 1998 | 4528 | ND | 3.6 (3.1 - 4.1) | (13) |
Study 2 | Fathimoghaddam (2011) | 2009 | 1652 | 794 | 1.4 (0.8 - 2) | (26) |
Study 3 | Shakeri (2013) | 2010 - 2011 | 3198 | 1021 | 1 (0.7 - 1.3) | (27) |
Total | 2 (0.4 - 3.6) | |||||
Sistan and Baluchestan | ||||||
Study 1 | Shahramian (2009) | 2008 | 458 | 221 | 3.5 (1.8 - 5.2) | (28) |
Study 2 | Salehi (2012) | 2010 | 3989 | 1835 | 3.4 (2.8 - 4) | (29) |
Total | 3.4 (2.9 - 3.9) | |||||
Southern Iran | Abedi (2011) | 2008 - 2009 | 4087 | 1292 | 1.5 (1.1 - 1.9) | (37) |
Tehran | Merat (2009)a | 2006 | 2327 | 968 | 2.3 (1.7 - 2.9) | (23) |
National | ||||||
Study 1 | Zali (1996) | 1991 | 39841 | ND | 1.7 (1.6 - 1.8) | (10) |
Study 2 | Zali (2005) | 1999 | 46631 | ND | 1.7 (1.6 - 1.8) | (11) |
Total | 1.7 (1.6 - 1.8) | |||||
Overall | 2.2 (1.9 - 2.6) |
Abbreviation: ND, not determine.
aThis study was conducted in Golestan, Hormozgan, and Tehran provinces.